AMGEN INC (AMGN)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
---|---|---|---|---|
Total revenues | 9,179 | 8,149 | 8,503 | 8,388 |
Other | - | - | 71 | 11 |
Selling, general and administrative | 1,691 | 1,687 | 1,625 | 1,785 |
Research and development | 1,744 | 1,486 | 1,450 | 1,447 |
Other | 77 | 830 | - | - |
Cost of sales | 3,011 | 2,968 | 3,310 | 3,236 |
Total operating expenses | 6,523 | 6,971 | 6,456 | 6,479 |
Operating income | 2,656 | 1,178 | 2,047 | 1,909 |
Other (expense) income, net | -394 | 1,518 | 1,830 | -307 |
Interest expense, net | 694 | 723 | 776 | 808 |
Income before income taxes | 1,568 | 1,973 | 3,101 | 794 |
Provision for income taxes | 136 | 243 | 271 | 48 |
Net income | 1,432 | 1,730 | 2,830 | 746 |
Basic (in shares) | 538,000,000 | 538,000,000 | 537,000,000 | 537,000,000 |
Basic (in usd per share) | 2.66 | 3.22 | 5.27 | 1.39 |
Diluted (in shares) | 541,000,000 | 541,000,000 | 542,000,000 | 541,000,000 |
Diluted (in usd per share) | 2.65 | 3.2 | 5.22 | 1.38 |